OptimizeRx Corp — Director's Dealing 2015

Jun 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2015-06-24

Reporting Person: BAKER DOUGLAS P (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-24	Stock Option	$1.05	J	0	Acquired	2020-05-12	Common Stock (100000)	Direct
2015-05-24	Stock Option	$1.05	A	100000	Acquired	2020-12-24	Common Stock (100000)	Direct

Footnotes

F1: The Issuer repriced the exercise price of the option from $1.72 to $1.05.

F2: The Stock Options vested as to 50% of the shares on May 12, 2015 and 50% of the shares will vest on May 12, 2016.

F3: The Stock Options will vest as to 50% of the shares on December 24, 2015 and 50% of the shares on June 24, 2016.